AHS Cancer Control Alberta

πŸ‡¨πŸ‡¦Canada
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

Conditions
Glioma
First Posted Date
2008-12-23
Last Posted Date
2014-10-03
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
20
Registration Number
NCT00813787
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

First Posted Date
2008-10-13
Last Posted Date
2019-08-22
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
23
Registration Number
NCT00771381
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

First Posted Date
2008-10-03
Last Posted Date
2014-10-03
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
30
Registration Number
NCT00765986
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Procedure: 3T MR Spectroscopy
First Posted Date
2008-09-22
Last Posted Date
2016-07-18
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
10
Registration Number
NCT00756392
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Withdrawn
Conditions
Hypoxic Tumours
Interventions
Other: 18F-FAZA
First Posted Date
2008-09-22
Last Posted Date
2017-11-14
Lead Sponsor
AHS Cancer Control Alberta
Registration Number
NCT00756691

A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy

Phase 2
Conditions
Anal Canal Cancer
Interventions
Radiation: Tomotherapy
First Posted Date
2008-09-17
Last Posted Date
2016-07-06
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
58
Registration Number
NCT00754078
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients

First Posted Date
2008-06-25
Last Posted Date
2014-10-01
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
30
Registration Number
NCT00705094
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

Phase 1
Withdrawn
Conditions
Glioblastoma
First Posted Date
2008-06-24
Last Posted Date
2016-02-22
Lead Sponsor
AHS Cancer Control Alberta
Registration Number
NCT00703859

Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating

First Posted Date
2008-06-05
Last Posted Date
2016-04-06
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
12
Registration Number
NCT00690963
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers

Phase 1
Completed
Conditions
Prostate Cancer
First Posted Date
2008-05-13
Last Posted Date
2016-07-06
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
26
Registration Number
NCT00676286
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Β© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy